Investigators aimed to determine rates and predictors of cirrhosis and cirrhosis-related complications in patients with chronic hepatitis B infection.
Drop in median price of WHO-prequalified generic tenofovir from 208 to 32 from 2004 to 2016
Adherence and completion to multidose vaccine schedules for hepatitis A, B, and A-B are low, thereby rendering vaccination ineffective.
The Work Group who authored the new recommendations was made up of professionals from academic medicine, federal and state public health agencies, and medical societies.
A patient's positive hepatitis B results were overlooked for 7 years.